{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T04:25:52Z","timestamp":1794716752803,"version":"4.9.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T00:00:00Z","timestamp":1718582400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009772","name":"Region Norrbotten","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018870","name":"Swedish Heart and Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004388","name":"Teva Branded Pharmaceutical Products R&D, Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004388","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.rmed.2024.107714","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T11:37:03Z","timestamp":1718451423000},"page":"107714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population"],"prefix":"10.1016","volume":"231","author":[{"given":"Sylvia","family":"Packham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8676-4647","authenticated-orcid":false,"given":"Maria","family":"\u00d6dling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-2690","authenticated-orcid":false,"given":"Apostolos","family":"Bossios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7745-8624","authenticated-orcid":false,"given":"Jon R.","family":"Konradsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Stridsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10379","key":"10.1016\/j.rmed.2024.107714_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2024.107714_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2023.107308","article-title":"Multiple manifestations of uncontrolled asthma increase the risk of severe COVID-19","volume":"216","author":"Selberg","year":"2023","journal-title":"Respir. Med."},{"issue":"11","key":"10.1016\/j.rmed.2024.107714_bib4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/cea.12963","article-title":"Increased prevalence of allergic asthma from 1996 to 2006 and further to 2016-results from three population surveys","volume":"47","author":"Backman","year":"2017","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.rmed.2024.107714_bib5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/1471-2458-12-204","article-title":"Global asthma prevalence in adults: findings from the cross-sectional world health survey","volume":"12","author":"To","year":"2012","journal-title":"BMC Publ. Health"},{"issue":"1","key":"10.1016\/j.rmed.2024.107714_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2020.1833412","article-title":"The Swedish National Airway Register (SNAR): development, design and utility to date","volume":"7","author":"Stridsman","year":"2020","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.rmed.2024.107714_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2019.105859","article-title":"One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting beta(2)-agonist in UK primary care settings","volume":"162","author":"Buhl","year":"2020","journal-title":"Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107714_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12931-018-0719-x","article-title":"Prevalence and management of severe asthma in primary care: an observational cohort study in Sweden (PACEHR)","volume":"19","author":"Larsson","year":"2018","journal-title":"Respir. Res."},{"issue":"5","key":"10.1016\/j.rmed.2024.107714_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/02770903.2020.1713150","article-title":"Uncontrolled asthma occurs in all GINA treatment steps and is associated with worse physical health - a report from the OLIN adult asthma cohort","volume":"58","author":"Stridsman","year":"2021","journal-title":"J. Asthma"},{"issue":"1","key":"10.1016\/j.rmed.2024.107714_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12890-020-1090-5","article-title":"Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review","volume":"20","author":"van Dijk","year":"2020","journal-title":"BMC Pulm. Med."},{"issue":"4","key":"10.1016\/j.rmed.2024.107714_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01872-2019","article-title":"Overuse of short-acting beta(2)-agonists in asthma is associated with increased risk of exacerbation and mortality: a nationwide cohort study of the global SABINA programme","volume":"55","author":"Nwaru","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107714_bib12","doi-asserted-by":"crossref","first-page":"851","DOI":"10.2147\/JAA.S292943","article-title":"High Use of SABAs is associated with higher exacerbation rate in Dutch patients with asthma","volume":"14","author":"Baron","year":"2021","journal-title":"J. Asthma Allergy"},{"issue":"3","key":"10.1016\/j.rmed.2024.107714_bib13","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s12325-020-01233-0","article-title":"SABINA: an Overview of short-acting beta(2)-agonist Use in asthma in European countries","volume":"37","author":"Janson","year":"2020","journal-title":"Adv. Ther."},{"key":"10.1016\/j.rmed.2024.107714_bib14","series-title":"Global Strategy for Asthma Management and Prevention 2023","year":"2023"},{"issue":"6","key":"10.1016\/j.rmed.2024.107714_bib15","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/j.jaip.2019.12.002","article-title":"Trajectory analyses of adherence Patterns in a real-life moderate to severe asthma population","volume":"8","author":"van Boven","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.rmed.2024.107714_bib16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.transproceed.2007.02.074","article-title":"Medication adherence in chronic disease: issues in posttransplant immunosuppression","volume":"39","author":"Hansen","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.rmed.2024.107714_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.rmed.2024.107714_bib18","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.jaip.2022.07.016","article-title":"Assessment of real-world escalation to biologics in US patients with asthma","volume":"10","author":"Bender","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2024.107714_bib19","article-title":"Behandlingsrekommendation: Astma hos barn och vuxna","year":"2023","journal-title":"Uppsala, L\u00e4kemedelsverket, mars 2023"},{"key":"10.1016\/j.rmed.2024.107714_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/217047","article-title":"Medication adherence measures: an Overview","volume":"2015","author":"Lam","year":"2015","journal-title":"BioMed Res. Int."},{"issue":"6","key":"10.1016\/j.rmed.2024.107714_bib21","first-page":"551","article-title":"Reference values for lung function tests in females. Regression equations with smoking variables","volume":"21","author":"Hedenstrom","year":"1985","journal-title":"Bull. Eur. Physiopathol. Respir."},{"issue":"3","key":"10.1016\/j.rmed.2024.107714_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3109\/03009738609178670","article-title":"Reference values for lung function tests in men: regression equations with smoking variables","volume":"91","author":"Hedenstrom","year":"1986","journal-title":"Ups. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.rmed.2024.107714_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaci.2006.01.011","article-title":"Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists","volume":"117","author":"Schatz","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2024.107714_bib24","series-title":"ICD-10 : International Statistical Classification of Diseases and Related Health Problems : Tenth Revision neWHO","article-title":"(2004)","year":"2004"},{"key":"10.1016\/j.rmed.2024.107714_bib25","series-title":"WHO Anatomical Therapeutic Chemical (ATC) Classification","year":"2023"},{"issue":"8","key":"10.1016\/j.rmed.2024.107714_bib26","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/thoraxjnl-2011-201096","article-title":"The relationship between clinical outcomes and medication adherence in difficult-to-control asthma","volume":"67","author":"Murphy","year":"2012","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.rmed.2024.107714_bib27","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1183\/09031936.00075614","article-title":"Medication adherence and the risk of severe asthma exacerbations: a systematic review","volume":"45","author":"Engelkes","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2024.107714_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00715-2020","article-title":"Long-term adherence to inhaled corticosteroids and asthma control in adult-onset asthma","volume":"7","author":"Vahatalo","year":"2021","journal-title":"ERJ Open Res"},{"issue":"4","key":"10.1016\/j.rmed.2024.107714_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00047-2023","article-title":"European Respiratory Society short guidelines for the use of as-needed ICS\/formoterol in mild asthma","volume":"62","author":"Papi","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"10202","key":"10.1016\/j.rmed.2024.107714_bib30","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(19)31948-8","article-title":"Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial","volume":"394","author":"Hardy","year":"2019","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.rmed.2024.107714_bib31","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa1901963","article-title":"Controlled trial of budesonide-formoterol as needed for mild asthma","volume":"380","author":"Beasley","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.rmed.2024.107714_bib32","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.chest.2021.09.004","article-title":"Revisiting mild asthma: current knowledge and Future Needs","volume":"161","author":"Mohan","year":"2022","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.rmed.2024.107714_bib33","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1164\/rccm.202304-0642ST","article-title":"Questions in mild asthma: an official American thoracic society research statement","volume":"207","author":"Mohan","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107714_bib34","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2147\/JAA.S357086","article-title":"Annual and post-exacerbation follow-up of asthma patients in clinical Practice - a large population-based study in Sweden","volume":"15","author":"Sandelowsky","year":"2022","journal-title":"J. Asthma Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2024.107714_bib35","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00491-2019","article-title":"Asthma progression and mortality: the role of inhaled corticosteroids","volume":"54","author":"O'Byrne","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2024.107714_bib36","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.jaip.2018.04.027","article-title":"Long-term trajectories of mild asthma in adulthood and risk factors of progression","volume":"6","author":"Chen","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.rmed.2024.107714_bib37","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1183\/13993003.00458-2015","article-title":"A repeated short educational intervention improves asthma control and quality of life","volume":"46","author":"Plaza","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2024.107714_bib38","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4187\/respcare.08778","article-title":"Comprehensive in-patient education consult for asthma exacerbations","volume":"67","author":"Baker","year":"2022","journal-title":"Respir. Care"},{"issue":"8","key":"10.1016\/j.rmed.2024.107714_bib39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.rmed.2015.05.004","article-title":"Benefits of an asthma education program provided at primary care sites on asthma outcomes","volume":"109","author":"Boulet","year":"2015","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2024.107714_bib40","series-title":"Global Strategy for Asthma Management and Prevention","year":"2018"},{"issue":"10","key":"10.1016\/j.rmed.2024.107714_bib41","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jaip.2022.06.026","article-title":"Digital inhalers and Remote patient Monitoring for asthma","volume":"10","author":"Mosnaim","year":"2022","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"7","key":"10.1016\/j.rmed.2024.107714_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S2213-2600(22)00534-3","article-title":"Use of digital measurement of medication adherence and lung function to guide the management of uncontrolled asthma (INCA Sun): a multicentre, single-blinded, randomised clinical trial","volume":"11","author":"Hale","year":"2023","journal-title":"Lancet Respir. Med."},{"issue":"12","key":"10.1016\/j.rmed.2024.107714_bib43","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.rmed.2015.10.015","article-title":"Medically treated exacerbations in COPD by GOLD 1-4: a valid, robust, and seemingly low-biased definition","volume":"109","author":"Ingebrigtsen","year":"2015","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.rmed.2024.107714_bib44","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1164\/rccm.202209-1774OC","article-title":"Exacerbation risk and mortality in global Initiative for chronic obstructive lung disease group A and B patients with and without exacerbation history","volume":"208","author":"Vanfleteren","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124001896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124001896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T23:20:21Z","timestamp":1722640821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124001896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":43,"alternative-id":["S0954611124001896"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107714","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107714"}}